Postprandial apolipoprotein B48- and B100-containing lipoproteins in type 2 diabetes: Do statins have a specific effect on triglyceride metabolism?

Metabolism: Clinical and Experimental

Volumn 49, Issue 8, 2000, Pages 1049-1054

  Battula, S B ^a   Fitzsimons, O ^a   Moreno, S ^a   Owens, D ^a   Collins, P ^a   Johnson, A ^a   Tomkin, G H ^a  

^a NONE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CERIVASTATIN; CHOLESTEROL; CHYLOMICRON; LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; DRUG EFFECT; FATTY ACID METABOLISM; FEMALE; HUMAN; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033892924     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.7744     Document Type: Article

References (44)

1. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: Post-prandial metabolism and relation to premature atherosclerosis
2. Intestinally-derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia
3. Alterations in apolipoprotein B-48 in the post-prandial state in non-insulin-dependent diabetes
4. Elevated triglyceride-rich lipoproteins in diabetes: A study of apolipoprotein B48
5. The role of dietary cholesterol in the regulation of post-prandial apolipoprotein B48 levels in diabetes
6. Postprandial lipoproteins and the progression of coronary atherosclerosis
7. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles
8. Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery
9. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death
10. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease
11. Apolipoprotein B48 or its apolipoprotein B100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor
12. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall - Evidence that plaque cholesterol may be derived from post-prandial lipoproteins
13. Role of plasma triglyceride in regulation of plasma low density lipoprotein (LDL): Relative contribution of small dense LDL to coronary heart disease risk
14. A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction
15. Regulation of low density lipoprotein size distribution in NIDDM and coronary artery disease: Importance of serum triglycerides
16. The influence of low density lipoprotein composition on its metabolism in non-insulin-dependent diabetes mellitus
17. Metabolic modes of action of the statins in hyperlipoproteinaemias
18. Improved metabolic control reduces the number of postprandial apolipoprotein B48-containing particles in type 2 diabetes
19. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
20. Determination of apolipoproteins B48 and B100 in triglyceride-rich lipoproteins by analytical SDS-PAGE
21. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
22. The role of diabetes in delayed chylomicron clearance
23. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on sterol absorption in hypercholesterolemic subjects
24. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion
25. The HMGCoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs
26. Postprandial plasma vitamin A metabolism in humans: A reassessment of use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants
27. Apolipoprotein B48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins
28. Inhibition of cholesterologenesis decreases hepatic secretion of apo B100 in normolipaemic subjects
29. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
30. Long-term regulation of lipolysis and hormone sensitive lipase by insulin and glucose
31. Uptake of hypertriglyceridaemic very low density lipoproteins and their remnants by HepG2 cells: The role of lipoprotein lipase, hepatic lipase, and cell surface proteoglycans
32. Tissue specific regulation of lipoprotein lipase activity by insulin/glucose in normal weight humans
33. Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: Evidence for reduced assembly and secretion of triglyceride-rich lipoproteins
34. Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidaemia: Increase in receptor activity, decrease in apo B production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach
35. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMGCoA reductase inhibitors, atorvastatin and simvastatin
36. NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B100 secretion from Hep G2 cells
37. Enhancement of fatty acid and cholesterol synthesis accompanied by enhanced biliary but not very-low-density lipoprotein lipid secretion following sustained pravastatin blockade of hydroxymethylglutaryl coenzyme A reductase in rat liver
38. HMGCoA reductase inhibitors perturb fatty acid metabolism in keratinocytes
39. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: Studies in randomly selected normo- and hypertriglyceridaemic men
40. 3-hydroxy-3-methylglutaryl coenzyme A reductase is present in peroxisomes in normal rat liver cells
41. Cholesterol synthesis in rat liver peroxisomes
42. Effects of particle size and number on the plasma clearance of chylomicrons and remnants
43. Effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
44. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)